2020-09-16 |
135 |
Opinion - Memorandum Opinion |
claims of U.S. Patent No. 10,130,589 (the "'589
Patent"), the patent asserted by the… regarding related patents, U.S. Patent Nos. 6,884,434 (the "'434 Patent")
and 8,232,…quot;'414 Patent"), and held the '414 Patent invalid and the '434 Patent
valid and … Book patents related to
Neupro® to determine whether any of them were 'blocking patents[,]"…and fourth,
UCB's other patents did not function as blocking patents. (D.I. 110 at 4-5.)
|
External link to document |
2019-08-02 |
18 |
Notice of Service |
Initial Infringement Contentions for U.S. Patent No. 10,130,589 B2 filed by LTS Lohmann Therapie-Systeme… 6 March 2019
1:19-cv-00474
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2021-04-07 |
196 |
Judgment |
2, 3, 7, 10, 11, and 12 of U.S. Patent No. 10,130,589 (the '589 Patent) are invalid.. Signed by Judge …3, 7, 10, 11, and 12 of U.S. Patent No. 10,130,589 (the '589 Patent)
are invalid.
SO…for relief requested in Plaintiffs' Complaint for Patent Infringement D.I. 1 are denied with prejudice; …relief requested in Plaintiffs'
Complaint for Patent Infringement (D.I. 1) are denied with prejudice… 6 March 2019
1:19-cv-00474
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2019-09-03 |
25 |
Notice of Service |
Invalidity Contentions with Respect to U.S. Patent No. 10,130,589 filed by Actavis Laboratories UT, Inc..(… 6 March 2019
1:19-cv-00474
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2019-03-05 |
4 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,130,589 B2. (nmg) (Entered… 6 March 2019
1:19-cv-00474
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |